One of our scouts alerted me to a remarkable editorial just published by Harrison, Brown and Raggi on the ezetimibe controversy [Harrison DG, Brown WV, Raggi P.
Enhanced hype. Am J Cardiol 2008; 102: 368-369. Link here , requires subscription.]
We have posted before (as have many others,) about problems with the ENHANCE trial of ezetimibe (Zetia , by Schering-Plough , and one component of Vytorin , by Merck ), and how...
Post new comment